论文部分内容阅读
欧洲血液和骨髓移植急性白血病工作组(European Blood and Marrow Transplantation AcuteLeukemia Working Party)成员称,自体造血干细胞移植(HSCT)作为患急性髓性白血病(AML)的儿童病情首次完全缓解时的巩固治疗是安全有效的。 以前对于自体HSCT和单纯化疗对AML患者
Members of the European Blood and Marrow Transplantation Acute Leukemia Working Party said that the consolidation of autologous hematopoietic stem cell transplantation (HSCT) as the first complete remission of children with acute myeloid leukemia (AML) is safe Effective. Previously for autologous HSCT and chemotherapy alone for AML patients